Loading...
menu
Search
AI Chat
AI Strategies
Products
Markets
News
Resources
Pricing
Home
ETF
IMRN
IMRN
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
IMRN News
B. Riley Financial Shares Surge Approximately 25%; Check Out 20 Stocks Making Moves in Premarket Trading
Dec 16 2025
Benzinga
UiPath Shares Rise Approximately 9%; Check Out 20 Stocks Making Moves in Premarket Trading
Dec 04 2025
Benzinga
Immuron Secures US Military Contract for New Oral Therapeutics Targeting Campylobacter and Shigella
Dec 03 2025
Globenewswire
Immuron Secures US Military Contract for Oral Therapeutics Development Targeting Campylobacter and Shigella
Dec 03 2025
Newsfilter
FDA Grants IND Approval for Immuron's IMM-529
Nov 05 2025
Newsfilter
Immuron Receives FDA Approval for IND Application of IMM-529
Nov 05 2025
NASDAQ.COM
Immuron Provides Update on Clinical Trial Progress
Oct 31 2025
Newsfilter
Join the Live Stream of Day 1 at the Emerging Growth Conference 87 on October 22. Register Now!
Oct 20 2025
Globenewswire
Immuron Reports Increase in Global Revenue for First Quarter
Oct 13 2025
NASDAQ.COM
Immuron Reports Year-Over-Year Growth for Q1 FY26
Oct 13 2025
Newsfilter
What’s Driving Immuron's Pre-market Surge?
Oct 08 2025
NASDAQ.COM
Join the Live Stream of Day 1 at the Emerging Growth Conference 85 on August 20; Registration Now Open
Aug 18 2025
Globenewswire
Why Interactive Brokers Group Shares Are Trading Higher By 5%; Here Are 20 Stocks Moving Premarket
Jul 18 2025
Benzinga
Immuron - FY25 global sales exceed projection, up 49% on prior year
Jul 17 2025
Newsfilter
Immuron exceeds AUD$5 million in sales in a fiscal year
Apr 11 2025
SeekingAlpha
Immuron Travelan® highest sales in history
Apr 10 2025
Newsfilter
Show More News
